Viewing nowCombinationTwinact Tablet 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.

MFDS item code 201605708 · Approved 2016.09.29 · Insurance code 678600680
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or telmisartan. It helps effectively lower blood pressure and reduce the risk of cardiovascular complications.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not adequately controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication should not be used during pregnancy, particularly during the second and third trimesters, as it can pose serious risks to the fetus. It should also not be administered to patients with hypersensitivity to this medication or those with certain cardiac diseases, liver dysfunctions, hypotension, or renal impairment. Blood pressure may occasionally drop too low, so patients with unstable blood pressure should be closely monitored and the dosage adjusted accordingly. Patients with impaired renal function or congestive heart failure also require special caution when using this medication. Side effects may include dizziness, peripheral edema, headache, and dyspepsia, and rarely, serious allergic reactions or liver function abnormalities may occur. Due to the risk of elevated potassium levels in the blood, patients at risk of hyperkalemia should undergo regular blood tests. While taking this medication, patients should be cautious about drowsiness or dizziness when driving or operating machinery. This drug may interact with other medications, so it is essential to inform healthcare professionals about any other drugs being taken. Breastfeeding women are advised not to take this medication, and if pregnancy is confirmed, it should be discontinued promptly. In case of overdose, severe hypotension or cardiac function impairment may occur, and any abnormal symptoms should prompt immediate medical attention. This drug is not recommended for children, and elderly patients should use it with caution and adjust the dosage accordingly. When stored, keep the medication out of reach of children and prevent moisture exposure.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a container that protects it from light. Additionally, it is essential to maintain a temperature between 1 and 30 degrees Celsius during storage to preserve the medication's effectiveness and safety.
Biconvex oval double-coated tablet in white and light gray.
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
(Co., Ltd.) CMG Pharmaceutical
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.